Click for best price
Tuberculosis Diagnostic Market Size, Share 2022
This report contains market size and forecasts of Tuberculosis Diagnostic in Global, including the following market information:
The global Tuberculosis Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radiographic Method Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tuberculosis Diagnostic include Thermo Fisher Scientific, Hologic Corporation, Abbott, Becton Dickinson, Roche, bioMerieux, Sanofi, Cepheid and Hain Lifescience and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tuberculosis Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tuberculosis Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Tuberculosis Diagnostic Market Segment Percentages, by Type, 2021 (%)
- Radiographic Method
- Diagnostic Laboratory Methods
- Nucleic Acid Testing
- Phage Assay
- Detection of Latent Infection
- Cytokine Detection Assay
- Detection of Drug Resistance
Global Tuberculosis Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Tuberculosis Diagnostic Market Segment Percentages, by Application, 2021 (%)
Global Tuberculosis Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Tuberculosis Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Tuberculosis Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Tuberculosis Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Thermo Fisher Scientific
- Hologic Corporation
- Abbott
- Becton Dickinson
- Roche
- bioMerieux
- Sanofi
- Cepheid
- Hain Lifescience
- QIAGEN
| Report Attributes |
Report Details |
| Report Title |
Tuberculosis Diagnostic Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tuberculosis Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tuberculosis Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tuberculosis Diagnostic Overall Market Size
2.1 Global Tuberculosis Diagnostic Market Size: 2021 VS 2028
2.2 Global Tuberculosis Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tuberculosis Diagnostic Players in Global Market
3.2 Top Global Tuberculosis Diagnostic Companies Ranked by Revenue
3.3 Global Tuberculosis Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Tuberculosis Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tuberculosis Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tuberculosis Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Tuberculosis Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Tuberculosis Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Tuberculosis Diagnostic Market Size Markets, 2021 & 2028
4.1.2 Radiographic Method
4.1.3 Diagnostic Laboratory Methods
4.1.4 Nucleic Acid Testing
4.1.5 Phage Assay
4.1.6 Detection of Latent Infection
4.1.7 Cytokine Detection Assay
4.1.8 Detection of Drug Resistance
4.2 By Type - Global Tuberculosis Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Tuberculosis Diagnostic Revenue, 2017-2022
4.2.2 By Type - Global Tuberculosis Diagnostic Revenue, 2023-2028
4.2.3 By Type - Global Tuberculosis Diagnostic Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tuberculosis Diagnostic Market Size, 2021 & 2028
5.1.2 Infants
5.1.3 Adults
5.2 By Application - Global Tuberculosis Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Tuberculosis Diagnostic Revenue, 2017-2022
5.2.2 By Application - Global Tuberculosis Diagnostic Revenue, 2023-2028
5.2.3 By Application - Global Tuberculosis Diagnostic Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Tuberculosis Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Tuberculosis Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Tuberculosis Diagnostic Revenue, 2017-2022
6.2.2 By Region - Global Tuberculosis Diagnostic Revenue, 2023-2028
6.2.3 By Region - Global Tuberculosis Diagnostic Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Tuberculosis Diagnostic Revenue, 2017-2028
6.3.2 US Tuberculosis Diagnostic Market Size, 2017-2028
6.3.3 Canada Tuberculosis Diagnostic Market Size, 2017-2028
6.3.4 Mexico Tuberculosis Diagnostic Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Tuberculosis Diagnostic Revenue, 2017-2028
6.4.2 Germany Tuberculosis Diagnostic Market Size, 2017-2028
6.4.3 France Tuberculosis Diagnostic Market Size, 2017-2028
6.4.4 U.K. Tuberculosis Diagnostic Market Size, 2017-2028
6.4.5 Italy Tuberculosis Diagnostic Market Size, 2017-2028
6.4.6 Russia Tuberculosis Diagnostic Market Size, 2017-2028
6.4.7 Nordic Countries Tuberculosis Diagnostic Market Size, 2017-2028
6.4.8 Benelux Tuberculosis Diagnostic Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Tuberculosis Diagnostic Revenue, 2017-2028
6.5.2 China Tuberculosis Diagnostic Market Size, 2017-2028
6.5.3 Japan Tuberculosis Diagnostic Market Size, 2017-2028
6.5.4 South Korea Tuberculosis Diagnostic Market Size, 2017-2028
6.5.5 Southeast Asia Tuberculosis Diagnostic Market Size, 2017-2028
6.5.6 India Tuberculosis Diagnostic Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Tuberculosis Diagnostic Revenue, 2017-2028
6.6.2 Brazil Tuberculosis Diagnostic Market Size, 2017-2028
6.6.3 Argentina Tuberculosis Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tuberculosis Diagnostic Revenue, 2017-2028
6.7.2 Turkey Tuberculosis Diagnostic Market Size, 2017-2028
6.7.3 Israel Tuberculosis Diagnostic Market Size, 2017-2028
6.7.4 Saudi Arabia Tuberculosis Diagnostic Market Size, 2017-2028
6.7.5 UAE Tuberculosis Diagnostic Market Size, 2017-2028
7 Players Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Corporate Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Major Product Offerings
7.1.4 Thermo Fisher Scientific Tuberculosis Diagnostic Revenue in Global Market (2017-2022)
7.1.5 Thermo Fisher Scientific Key News
7.2 Hologic Corporation
7.2.1 Hologic Corporation Corporate Summary
7.2.2 Hologic Corporation Business Overview
7.2.3 Hologic Corporation Tuberculosis Diagnostic Major Product Offerings
7.2.4 Hologic Corporation Tuberculosis Diagnostic Revenue in Global Market (2017-2022)
7.2.5 Hologic Corporation Key News
7.3 Abbott
7.3.1 Abbott Corporate Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Tuberculosis Diagnostic Major Product Offerings
7.3.4 Abbott Tuberculosis Diagnostic Revenue in Global Market (2017-2022)
7.3.5 Abbott Key News
7.4 Becton Dickinson
7.4.1 Becton Dickinson Corporate Summary
7.4.2 Becton Dickinson Business Overview
7.4.3 Becton Dickinson Tuberculosis Diagnostic Major Product Offerings
7.4.4 Becton Dickinson Tuberculosis Diagnostic Revenue in Global Market (2017-2022)
7.4.5 Becton Dickinson Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Tuberculosis Diagnostic Major Product Offerings
7.5.4 Roche Tuberculosis Diagnostic Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
7.6 bioMerieux
7.6.1 bioMerieux Corporate Summary
7.6.2 bioMerieux Business Overview
7.6.3 bioMerieux Tuberculosis Diagnostic Major Product Offerings
7.6.4 bioMerieux Tuberculosis Diagnostic Revenue in Global Market (2017-2022)
7.6.5 bioMerieux Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Tuberculosis Diagnostic Major Product Offerings
7.7.4 Sanofi Tuberculosis Diagnostic Revenue in Global Market (2017-2022)
7.7.5 Sanofi Key News
7.8 Cepheid
7.8.1 Cepheid Corporate Summary
7.8.2 Cepheid Business Overview
7.8.3 Cepheid Tuberculosis Diagnostic Major Product Offerings
7.8.4 Cepheid Tuberculosis Diagnostic Revenue in Global Market (2017-2022)
7.8.5 Cepheid Key News
7.9 Hain Lifescience
7.9.1 Hain Lifescience Corporate Summary
7.9.2 Hain Lifescience Business Overview
7.9.3 Hain Lifescience Tuberculosis Diagnostic Major Product Offerings
7.9.4 Hain Lifescience Tuberculosis Diagnostic Revenue in Global Market (2017-2022)
7.9.5 Hain Lifescience Key News
7.10 QIAGEN
7.10.1 QIAGEN Corporate Summary
7.10.2 QIAGEN Business Overview
7.10.3 QIAGEN Tuberculosis Diagnostic Major Product Offerings
7.10.4 QIAGEN Tuberculosis Diagnostic Revenue in Global Market (2017-2022)
7.10.5 QIAGEN Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Tuberculosis Diagnostic Market Opportunities & Trends in Global Market
Table 2. Tuberculosis Diagnostic Market Drivers in Global Market
Table 3. Tuberculosis Diagnostic Market Restraints in Global Market
Table 4. Key Players of Tuberculosis Diagnostic in Global Market
Table 5. Top Tuberculosis Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tuberculosis Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tuberculosis Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tuberculosis Diagnostic Product Type
Table 9. List of Global Tier 1 Tuberculosis Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tuberculosis Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Tuberculosis Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tuberculosis Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tuberculosis Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Tuberculosis Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tuberculosis Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tuberculosis Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Tuberculosis Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tuberculosis Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tuberculosis Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tuberculosis Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tuberculosis Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tuberculosis Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tuberculosis Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tuberculosis Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Tuberculosis Diagnostic Product Offerings
Table 32. Thermo Fisher Scientific Tuberculosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Hologic Corporation Corporate Summary
Table 34. Hologic Corporation Tuberculosis Diagnostic Product Offerings
Table 35. Hologic Corporation Tuberculosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Corporate Summary
Table 37. Abbott Tuberculosis Diagnostic Product Offerings
Table 38. Abbott Tuberculosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. Becton Dickinson Corporate Summary
Table 40. Becton Dickinson Tuberculosis Diagnostic Product Offerings
Table 41. Becton Dickinson Tuberculosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Tuberculosis Diagnostic Product Offerings
Table 44. Roche Tuberculosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. bioMerieux Corporate Summary
Table 46. bioMerieux Tuberculosis Diagnostic Product Offerings
Table 47. bioMerieux Tuberculosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Tuberculosis Diagnostic Product Offerings
Table 50. Sanofi Tuberculosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. Cepheid Corporate Summary
Table 52. Cepheid Tuberculosis Diagnostic Product Offerings
Table 53. Cepheid Tuberculosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. Hain Lifescience Corporate Summary
Table 55. Hain Lifescience Tuberculosis Diagnostic Product Offerings
Table 56. Hain Lifescience Tuberculosis Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. QIAGEN Corporate Summary
Table 58. QIAGEN Tuberculosis Diagnostic Product Offerings
Table 59. QIAGEN Tuberculosis Diagnostic Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Tuberculosis Diagnostic Segment by Type in 2021
Figure 2. Tuberculosis Diagnostic Segment by Application in 2021
Figure 3. Global Tuberculosis Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tuberculosis Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tuberculosis Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tuberculosis Diagnostic Revenue in 2021
Figure 8. By Type - Global Tuberculosis Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tuberculosis Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tuberculosis Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tuberculosis Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tuberculosis Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tuberculosis Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tuberculosis Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tuberculosis Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tuberculosis Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Tuberculosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Hologic Corporation Tuberculosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Tuberculosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Becton Dickinson Tuberculosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Tuberculosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. bioMerieux Tuberculosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Tuberculosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cepheid Tuberculosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Hain Lifescience Tuberculosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. QIAGEN Tuberculosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
